Switch to Francois Benard's research page...

2008

1. Dubuc C, Langlois R, Benard F, Cauchon N, Klarskov K, Tone P, van Lier JE. Targeting gastrin-releasing peptide receptors of prostate cancer cells for photodynamic therapy with a phthalocyanine-bombesin conjugate. Bioorg Med Chem Lett (2008).
    [View Abstract - PubMed 18329268]  Request Paper

2007

2. Ahmed N, Dubuc C, Rousseau J, Benard F, van Lier JE. Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates. Bioorg Med Chem Lett 17:3212-6 (2007).
    [View Abstract - PubMed 17379515]  Request Paper

3. Ahmed N, Langlois R, Rodrigue S, Benard F, van Lier JE. Automated synthesis of 11beta-methoxy-4,16alpha-[16alpha-(18)F]difluoroestradiol (4F-M[(18)F]FES) for estrogen receptor imaging by positron emission tomography. Nucl Med Biol 34:459-64 (2007).
    [View Abstract - PubMed 17499736]  Request Paper

4. Aliaga A, Rousseau JA, Cadorette J, Croteau E, van Lier JE, Lecomte R, Benard F. A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-D-glucose in murine models of breast cancer. Mol Imaging Biol 9:144-50 (2007).
    [View Abstract - PubMed 17334852]  Request Paper

5. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A, Iwanochko RM; PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 50:2002-12 (2007).
    [View Abstract - PubMed 17996568]  Request Paper

6. Beauregard JM, Croteau E, Ahmed N, Ouellette R, van Lier JE, Benard F. Effective specific activities determined by scintillation proximity counting for production runs of [(18)F]FES and 4F-M[(18)F]FES. Nucl Med Biol 34:325-9 (2007).
    [View Abstract - PubMed 17383582]  Request Paper

7. Tremblay S, Ouellet R, Rodrigue S, Langlois R, Benard F, Cunnane SC. Automated synthesis of 11C-acetoacetic acid, a key alternate brain fuel to glucose. Appl Radiat Isot 65:934-40 (2007).
    [View Abstract - PubMed 17544283]  Request Paper

2006

8. Ci X, Frisch F, Lavoie F, Germain P, Lecomte R, van Lier JE, Benard F, Carpentier AC. The Effect of Insulin on the Intracellular Distribution of 14(R,S)-[(18)F]Fluoro-6-thia-heptadecanoic Acid in Rats. Mol Imaging Biol (2006).
    [View Abstract - PubMed 16645919]  Request Paper

9. Leboeuf R, Benard F, Langlois MF. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid. Clin Nucl Med 31(7):382-5 (2006).
    [View Abstract - PubMed 16785803]  Request Paper

10. Prevost S, Boucher L, Larivee P, Boileau R, Benard F. Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer. J Nucl Med 47(4):559-65. (2006).
     [View Abstract - PubMed 16595487]  Request Paper

11. Prevost S, Boucher L, Larivee P, Boileau R, Benard F. Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer. J Nucl Med 47:559-65. (2006).
     [View Abstract - PubMed 16595487]  Request Paper

12. Turcotte E, Leblanc M, Carpentier A, Benard F. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D: -glucose Injection following I.V. Insulin in diabetic patients. Mol Imaging Biol 8:348-54. (2006).
     [View Abstract - PubMed 17053859]  Request Paper

2004

13. Aliaga A, Rousseau JA, Ouellette R, Cadorette J, van Lier JE, Lecomte R, Benard F.. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging. Nucl Med Biol 31:761-70 (2004).
     [View Abstract - PubMed 15246367]  Request Paper

14. Boucher L, Rodrigue S, Lecomte R, Benard F. Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results. J Nucl Med 45:214-9 (2004).
     [View Abstract - PubMed 14960638]  Request Paper

15. Croteau E, Benard F, Bentourkia M, Rousseau J, Paquette M, Lecomte R. Quantitative myocardial perfusion and coronary reserve in rats with 13N-ammonia and small animal PET: impact of anesthesia and pharmacologic stress agents. J Nucl Med 45:1924-30 (2004).
     [View Abstract - PubMed 15534064]  Request Paper

16. Seimbille Y, Benard F, Rousseau J, Pepin E, Aliaga A, Tessier G, van Lier JE. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780). Nucl Med Biol 31:691-8 (2004).
     [View Abstract - PubMed 15246359]  Request Paper

17. Seimbille Y, Benard F, Rousseau J, Pepin E, Aliaga A, Tessier G, van Lier JE. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780). Nucl Med Biol 31:691-8 (2004).
     [View Abstract - PubMed 15246359]  Request Paper

2003

18. Beanlands R, Nichol G, Ruddy TD, deKemp RA, Hendry P, Humen D, Racine N, Ross H, Benard F, Coates G, Iwanochko RM, Fallen E, Wells G; PARR-2 Investigators. Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods. Control Clin Trials 24:776-94. (2003).
     [View Abstract - PubMed 14662282]  Request Paper

19. Croteau E, Benard F, Cadorette J, Gauthier ME, Aliaga A, Bentourkia M, Lecomte R. Quantitative gated PET for the assessment of left ventricular function in small animals. J Nucl Med 44:1655-61 (2003).
     [View Abstract - PubMed 14530482]  Request Paper

20. Guay C, Lepine M, Verreault J, Benard F. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation. J Nucl Med 44:1225-31 (2003).
     [View Abstract - PubMed 12902411]  Request Paper

2005

1. Benard F, Turcotte E. Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography. Breast Cancer Res 7(4):153-62 (2005).
    [View Abstract - PubMed 15987467]  Request Paper

2. Mielniczuk L, DeKemp RA, Dennie C, Yoshinaga K, Burwash IG, Benard F, Haddad H, Beanlands DS, Beanlands RS. Images in cardiovascular medicine. Fluorine-18-labeled deoxyglucose positron emission tomography in the diagnosis and management of aortitis with pulmonary artery involvement. Circulation 111(22):e375-6 (2005).
    [View Abstract - PubMed 15939826]  Request Paper

2003

3. Benard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 33:148-62. (2003).
    [View Abstract - PubMed 12756647]  Request Paper

1. Lamontagne F, Benard F, Lesur O. Positron emission tomography: anticipated usefulness in Critical Care Setting. in Yearbook of Intensive Care and Emergency Medicine 2003: Vincent JL ed. Springer (2003).
    Request Paper